Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

New GLP-1 receptor agonists identified at ILDONG Pharmaceutical

June 10, 2021

Yuhan Corp. and Green Cross Corp. present ceramide glucosyltransferase inhibitors

June 9, 2021

New mucolipin-1 activators identified at Libra Therapeutics

June 9, 2021

Bayer identifies new PTGER3 antagonists

June 7, 2021

LG Chem discloses new melanocortin MC4 receptor agonists

June 4, 2021

Karolinska announces that Dilafor successfully concluded its phase IIb study of tafoxiparin

June 4, 2021

Crinetics Pharmaceuticals synthesizes new melanocortin MC2 receptor antagonists

June 3, 2021

ADO-09 shown to be superior to insulin aspart in type 1 diabetes patients

June 3, 2021

Diverse cohort expands diabetes genomics

June 2, 2021

SCOHIA advances somatostatin SST5 receptor antagonist SCO-240 into phase I study

May 31, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.